Asian lung cancer patient survival exceeds Caucasians' on multiple regimens
Wednesday, June 1, 2011 - 09:01
in Health & Medicine
Asian non-small cell lung cancer (NSCLC) patients survive longer than Caucasians no matter how many drugs are given in a first-line setting, and the effect was apparent both before and after the introduction of targeted therapies in the early 2000s, according to research published in the June issue of the Journal of Thoracic Oncology.